Article
SpyPhage: A Cell-Free TXTL Platform for Rapid Engineering of Targeted Phage Therapies
4 Oct 2022
Abstract excerpt
The past decade has seen the emergence of multidrug resistant pathogens as a leading cause of death worldwide, reigniting interest in the field of phage therapy. Modern advances in the genetic engineering of bacteriophages have enabled several useful results including host range alterations, constitutive lytic growth, and control over phage replication. However, the slow licensing process of genetically modified...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
